Market Highlights
Serotonin is a chemical produced by the body which enables brain cells and other nervous system cells to communicate with one another. Serotonin syndrome occurs when taking medicines meddle with the serotonin levels in the body. Serotonin syndrome is typically caused by synergistic effect of two or more serotonergic drugs which generally include selective serotonin reuptake inhibitor (SSRI), serotonin norepinephrine reuptake inhibitor (SNRI), monoamine oxidase inhibitor (MAOI), tricyclic antidepressants (TCAs), amphetamines etc. Other drugs with a high propensity of causing serotonin syndrome are dextromethorphan, buspirone, L-tryptophan, St. John's wort, metoclopramide, ondansetron etc. There is no laboratory test to confirm the diagnosis of serotonin syndrome.

Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death. The 1984 case of Libby Zion is a confirmed case of death from serotonin syndrome.
The treatment for serotonin syndrome consists of discontinuing medications contributing to the condition and gastrointestinal decontamination using activated charcoal for serious cases. Symptomatic treatment involves using sedatives such as benzodiazepines for agitated patients, cooling measures for managing hyperthermia. Serotonin antagonist such as cyproheptadine may be needed are also found to be useful.

The market restraints are the low number of cases and the low number of fatalities associated with the syndrome with less than 1% cases consuming serotonin syndrome causing drugs developing the diseases. Mild symptoms occur in about 15% of SSRI overdoses. Other market restrain is the low profitability of operating in the drugs segment used for the symptomatic treatment of serotonin syndrome.
Considering all these factors, the market for serotonin syndrome diagnosis and treatment is expected to grow at a CAGR of ~ 2.3% during 2017-2023.

Key players of Global Serotonin syndrome market:
• AstraZeneca Plc.,
• Eli Lilly and Company,
• Forest Laboratories Inc.,
• GlaxoSmithKline plc.,
• Johnson & Johnson,
• Merck & Co., Inc.,
• Pfizer, Inc. and Sanofi S.A.,
• Ciron Drugs & Pharmaceuticals Pvt. Ltd.
• others.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/4075

Segmentation:
The global serotonin syndrome market is segmented on the basis of drug treatment, and end users.
Based on drug treatment, the market has been segmented as serotonin antagonists, supportive care (Muscle relaxants, the control of autonomic instability, anti-hyperthermics, antihypertensive and others.
Based on the end users, the market has been segmented as hospitals, point of care and others.

Intended Audience
• Global Serotonin syndrome diagnosis and treatment solutions, manufacturers & suppliers
• Research and development (R&D) companies
• Hospitals and clinics
• Academic institutes and universities

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Serotonin Syndrome Market Research Report- Global Forecast till 2023”

Access Report Details @ https://www.marketresearchfuture.com/reports/serotonin-syndrome-market-4075

Table of Content

1. Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4. Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Serotonin Syndrome Market, By Drug Treatment
5.1 Serotonin Antagonists
5.2 Supportive Care
5.2.1 Muscle Relaxants
5.2.2 Sedatives
5.2.3 Anti-Hyperthermics
5.2.4 Antihypertensive
5.2.5 Others
5.3 Gastrointestinal Decontamination
5.4 Others
6. Global Serotonin Syndrome Market, By End Users
Continue……………

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]